Table: Xebio Holdings - 9-MTH group results
Feb 12 (Reuters)-
Xebio Holdings Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2020 Dec 31, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 149.66 173.95 207.59
(-14.0 pct) (-0.2 pct) (-7.9 pct)
Operating 2.43 4.58 3.05
(-47.0 pct) (-30.2 pct) (-41.9 pct)
Recurring 3.09 5.02 3.75
(-38.3 pct) (-29.5 pct) (-35.8 pct)
Net 888 mln 1.66 149 mln
(-46.3 pct) (-54.7 pct) (-63.3 pct)
EPS 20.10 yen 37.45 yen 3.38 yen
EPS Diluted 20.04 yen 37.35 yen
Ann Div 32.50 yen 30.00 yen
-Q2 div 15.00 yen 17.50 yen
-Q4 div 15.00 yen 15.00 yen
NOTE - Xebio Holdings Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=8281.T